Jenscare Scientific’s Ken Valve Receives NMPA Marketing Approval
Jenscare Scientific Co., Ltd (HKG: 9877), a Ningbo-based structural heart disease device maker, has announced...
Jenscare Scientific Co., Ltd (HKG: 9877), a Ningbo-based structural heart disease device maker, has announced...
Hangzhou-based Oriomics, a cancer screening specialist backed by Hotgen Biotech Co., Ltd (SHA: 688068), has...
The National Medical Products Administration (NMPA) has released a notification on further adjusting and optimizing...
Broncus Medical Inc., a provider of precision intervention solutions for lung diseases with operations in...
China-based Lifetech Scientific Corporation (HKG: 1302) has announced obtaining medical insurance coverage in the United...
US medical device and life sciences giant GE Healthcare Technologies Inc. (NASDAQ: GEHC) has announced...
Australia-based Telix Pharmaceuticals Ltd (ASX: TLX) announced receiving clearance from the Brazilian Health Regulatory Agency...
US medical device and life sciences giant GE Healthcare Technologies Inc. (NASDAQ: GEHC) announced the...
Israel-based IceCure Medical Ltd. (NASDAQ: ICCM) announced receiving patent authorization from the China National Intellectual...
China-based Lifetech Scientific Corporation (HKG: 1302) announced receiving market approval from the National Medical Products...
China’s National Medical Products Administration (NMPA) has approved ROBO Medical’s gastrointestinal endoscopic surgical instrument control...
US-based Inari Medical, Inc. (NASDAQ: NARI), set to be acquired by Stryker (NYSE: SYK), announced...
Shanghai MicroPort Endovascular MedTech Co., Ltd’s (SHA: 688016) Cratos branched aortic stent graft system has...
Suzhou-based Gaush Meditech Ltd (HKG: 2407) announced receiving market approval from the National Medical Products...
Suzhou-based Gaush Meditech Ltd (HKG: 2407) announced receiving market approval from the National Medical Products...
US major Johnson & Johnson MedTech announced receiving U.S. 510(k) regulatory clearance for its MONARCH...
China’s National Healthcare Security Administration (NHSA) has released the “Guidelines for the Pricing Project Initiation...
Shanghai-based Huihe Healthcare, a developer of structural heart disease intervention medical devices, announced receiving marketing...
China-based Jiangsu Cowin Biotech Co., Ltd. (SHA: 688426) announced receiving a Category III medical device...
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) announced plans to invest RMB130 million...